This is a type of leukemia involving large lymphocytes with granules. It can affect humans and can sometimes be serious.
Every report comes from a Lived member, sent anonymously.
Have you tried Methotrexate for Large Granular Lymphocytic Leukemia?
Large granular lymphocytic (LGL) leukemia is a rare blood cancer in which one family of immune cells, called large granular lymphocytes, keeps multiplying instead of dying off on schedule. These cells normally help fight viruses. In LGL leukemia, a single clone of them persists and releases signals that suppress the bone marrow, so the main problem is usually not the extra lymphocytes themselves but a shortage of other blood cells. Low neutrophils, the white blood cells that fight bacteria, are the most common result, followed by anemia (low red blood cells) and, less often, low platelets. Unlike most leukemias, LGL leukemia usually behaves like a slow, chronic condition. Many people have no symptoms when it is found on a routine blood test, and some never need treatment. There are two main types. T-cell LGL leukemia accounts for most cases, and natural killer (NK) cell LGL leukemia makes up roughly one in ten. Aggressive NK-cell leukemia shares part of the name but is a different, rare disease that progresses quickly and needs urgent specialist treatment, so getting the type right matters.
The exact cause is not known. A leading explanation is that the cells start out responding normally to a long-lasting trigger, possibly a virus, and then acquire genetic changes that stop them from shutting down afterward. Changes in a gene called STAT3 are found in a large share of cases. These changes develop during life in the blood cells only, so the condition is not inherited and is not passed to children. LGL leukemia is closely tied to autoimmune disease. About a third of people have a related autoimmune or bone marrow condition, most often rheumatoid arthritis, which affects roughly a fifth to a third of people with the T-cell type. It is mostly diagnosed in people in their 50s and 60s and is rare under 40. A temporary rise in these cells can also follow viral infections such as cytomegalovirus (CMV), HIV or Epstein-Barr virus, but that kind of reactive increase is not leukemia.
LGL leukemia is usually suspected when a blood test shows unexplained low neutrophils, anemia, a raised lymphocyte count or repeated infections, sometimes in someone who already has rheumatoid arthritis. Under the microscope, the cells look distinctive: larger than ordinary lymphocytes, with visible granules. Confirming the diagnosis means showing that the extra cells come from a single clone. Flow cytometry, a test that sorts blood cells by the markers on their surface, identifies whether they are T cells or NK cells and rules out look-alike conditions. For the T-cell type, a T-cell receptor gene rearrangement test shows whether the cells share one origin. Testing for STAT3 changes is often added. Because blood counts can be low for many reasons, and a temporary increase in these cells can follow an infection, clinicians look for a pattern that persists over months. A bone marrow biopsy is not always required, but it is often done to check for other marrow diseases and can help when the blood count of these cells is not very high.
Treatment is based on blood counts and symptoms, not on how many LGL cells are present. Many people start with watchful waiting: regular checkups and blood tests, with treatment held until it is needed. Treatment is generally recommended when the absolute neutrophil count falls below about 500 per microliter or infections keep recurring, when hemoglobin (the oxygen-carrying protein measured to gauge anemia) falls below about 8 g/dL or regular transfusions are needed, when platelets fall very low, or when a related autoimmune condition such as rheumatoid arthritis needs control. The usual first treatments are medicines that calm the immune system: low-dose methotrexate, cyclophosphamide or cyclosporine, usually taken by mouth. Methotrexate and cyclophosphamide are also chemotherapy drugs, but here they are used at much lower doses, so side effects are usually milder than in cancer chemotherapy. Methotrexate is often chosen when neutropenia or rheumatoid arthritis is the main issue, and cyclophosphamide when the marrow has stopped making red blood cells. These medicines take time, and a response is usually judged after about four months. Each helps roughly half to about six in ten people, the improvement is often partial, and relapse is common, so people may move through more than one option. Treatment requires regular blood tests to watch for side effects. Supportive care can matter as much as the leukemia treatment itself. Injections that boost neutrophil production, blood transfusions and treatment of infections help keep people well. When standard options fail, other immune-suppressing drugs, spleen removal or, rarely, a stem cell transplant may be considered, and newer targeted drugs are being studied in clinical trials. There is no standard cure, but treatment often restores safer blood counts for long periods.
For most people, LGL leukemia is a long-term condition to be managed rather than a rapidly spreading cancer. Some people go years with stable counts and no treatment. Others need treatment soon after diagnosis or cycle through periods of treatment and remission. Older studies put median survival at around nine to ten years, but they included older and sicker patients, and more recent registry experience suggests many people diagnosed today live close to a normal lifespan. Older age and other serious illnesses weigh more heavily on outlook than the leukemia itself. Day to day, the main concerns are infections and tiredness. People with low neutrophils may get frequent skin, mouth or throat infections, and anemia can cause fatigue and breathlessness. Some people also feel flu-like or run low fevers without a clear infection, but with low neutrophils a new fever should still be reported as described below. Ongoing care usually means blood tests every few weeks to months, more often during treatment, and coordination with a rheumatologist when arthritis is involved. Because the condition is rare, care at or in consultation with a center experienced in LGL leukemia can be helpful.
Ask for an evaluation, including a referral to a hematologist (a blood specialist), when blood tests repeatedly show low neutrophils, unexplained anemia or a raised lymphocyte count, or when infections keep coming back. Once diagnosed, report new fatigue, breathlessness, easy bruising or a swollen, uncomfortable abdomen at your next contact so blood counts can be rechecked. If your neutrophil count is known to be low, a fever or signs of a significant infection, such as chills, a spreading red skin infection or painful sores in the mouth or around the anus, need a call to your care team right away, not later in the day, because infections can become serious quickly when neutrophils are low. If you feel very unwell, become confused or faint, or are breathing fast, get emergency care, since these can be signs of sepsis, a severe body-wide reaction to infection.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Large Granular Lymphocytic Leukemia is like, what's helped you, or ask the community a question.